RadNet, Inc. has entered into a merger agreement with OnRad, Inc., a move that could significantly bolster its presence in the medical laboratory services sector. This agreement, filed with the SEC on October 26, 2026, marks a pivotal moment for the company as it seeks to expand its operational capabilities and market share.
RadNet, a Delaware corporation, is recognized for its extensive network of outpatient imaging centers. The company operates under the Standard Industrial Classification (SIC) of 8071, which encompasses services related to medical laboratories. The merger with OnRad is expected to create synergies that enhance service delivery and operational efficiency.
According to the SEC filing (accession number 0001683168-26-008094), the merger will involve a two-step process. First, Javelin Merger Sub, Inc., a subsidiary of RadNet, will merge with OnRad, allowing OnRad to continue as a wholly owned subsidiary. Following this, OnRad will merge into RadNet’s subsidiary, further consolidating operations.
As part of the merger, OnRad's shareholders will receive $350 million in cash and 5 million shares of RadNet common stock, subject to customary adjustments. Additionally, there is potential for an earn-out payment of up to $210 million based on OnRad's performance in the fiscal year ending December 31, 2027. This structure is designed to align the interests of OnRad's shareholders with RadNet's long-term growth objectives.
The merger is subject to several conditions, including obtaining necessary regulatory approvals and stockholder consent from OnRad. The parties involved have already filed under the Hart-Scott-Rodino Antitrust Improvements Act, indicating that the merger has cleared initial antitrust scrutiny.
RadNet’s strategic move to acquire OnRad underscores its commitment to growth and innovation in the medical laboratory services industry. This merger may also influence market dynamics, potentially affecting competitors in the sector.
What's next for RadNet involves navigating the regulatory landscape and securing the required stockholder approvals. The merger is anticipated to close in early 2027, pending these conditions. The filing does not specify what happens next beyond these requirements.